Try our beta test site

Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax

This study is currently recruiting participants. (see Contacts and Locations)
Verified February 2017 by Cancer Insight, LLC
Sponsor:
Collaborators:
Genentech, Inc.
Galena Biopharma, Inc.
Information provided by (Responsible Party):
George E. Peoples, Cancer Insight, LLC
ClinicalTrials.gov Identifier:
NCT01570036
First received: March 25, 2012
Last updated: February 23, 2017
Last verified: February 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2019
  Estimated Primary Completion Date: December 2017 (Final data collection date for primary outcome measure)